| Code | 3669D | ||||||||||
| MA number | 58/0039/20-S | ||||||||||
| Product Form: | cps pld 30x90 mg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 20.03.2020 |
| Validity: | 20.03.2025 |
| MA renewed: | Renewal application submitted |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Urapidil Stada 90 mg_cps pld_03/2020_REG.doc
|
| SPC: |
SPC_Urapidil Stada 90 mg_cps pld_03/2020_REG.doc
|
| Safety feature | Yes |
| Data update: | 26.03.2020 |
